Vildagliptin [Galvus; Novartis] has been approved in Europe as a once-daily oral treatment for type 2 diabetes mellitus

Source: Inpharma, Volume 1, Number 1608, 2007-10-06 , pp. 23-23(1)

Publisher: Adis International

Keywords: Development-status; Product-approvals; Research-and-development; Type-2-diabetes-mellitus, treatment; Vildagliptin, therapeutic use

Document Type: Short communication

Publication date: 2007-01-01

• In this: publication
• By this: publisher
• In this Subject: Pharmacology

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers